These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Immunotherapy: new hope for the cancer patient. Costanzi JJ; Goldstein AL Am Fam Physician; 1973 Nov; 8(5):150-4. PubMed ID: 4542856 [No Abstract] [Full Text] [Related]
3. Unresolved questions in clinical T cell vaccination. Cohen IR Br J Rheumatol; 1991; 30 Suppl 2():17-9. PubMed ID: 1993250 [No Abstract] [Full Text] [Related]
4. Immunization with T cell receptor peptides. Vandenbark AA; Chou YK; Hashim G; Offner H Br J Rheumatol; 1991; 30 Suppl 2():20-3. PubMed ID: 1993251 [No Abstract] [Full Text] [Related]
5. Modulating T-cell immunity to tumours: new strategies for monitoring T-cell responses. Yee C; Greenberg P Nat Rev Cancer; 2002 Jun; 2(6):409-19. PubMed ID: 12189383 [No Abstract] [Full Text] [Related]
6. Current concepts of cellular immunity and their therapeutic implications. Raska K; Raskova J; Raska K Clin Ther; 1987; 9(3):244-56. PubMed ID: 3300987 [No Abstract] [Full Text] [Related]
7. [The function of the T immunity system in patients with hemoblastoses undergoing polychemotherapy]. Zverkova AS; Bratus' GG Vrach Delo; 1991 Feb; (2):39-43. PubMed ID: 2058119 [TBL] [Abstract][Full Text] [Related]
8. [Editorial: The thymus, key organ of immunity]. Bach JF Nouv Presse Med; 1974 Mar; 3(10):571-4. PubMed ID: 4545037 [No Abstract] [Full Text] [Related]
9. [Effect of T-activin on various immunity indices and severity of experimental herpetic keratitis]. Mikuli SG; Arion VIa; Maĭchuk IuF; Krotova SN; Demchenko LG Oftalmol Zh; 1983; 38(1):41-5. PubMed ID: 6602959 [No Abstract] [Full Text] [Related]
10. Cancer immunotherapy: a treatment for the masses. Blattman JN; Greenberg PD Science; 2004 Jul; 305(5681):200-5. PubMed ID: 15247469 [TBL] [Abstract][Full Text] [Related]
11. Acceleration of allogeneic antitumor immunity with immune RNA in vitro and T-cell suppression by L1210 tumor bearer spleen cells. Miura T; Maekawa T; Kurashige S; Mitsuhashi S Cancer Res; 1981 Feb; 41(2):383-98. PubMed ID: 6160907 [TBL] [Abstract][Full Text] [Related]
12. Augmenting major histocompatibility complex class I expression by murine tumors in vivo enhances antitumor immunity induced by an active immunotherapy strategy. Merritt RE; Yamada RE; Crystal RG; Korst RJ J Thorac Cardiovasc Surg; 2004 Feb; 127(2):355-64. PubMed ID: 14762342 [TBL] [Abstract][Full Text] [Related]
13. [Perspectives for the immunotherapy of condylomata]. Bourgault Villada I Ann Dermatol Venereol; 2000; 127(10 Suppl):3S23-3S25. PubMed ID: 11116860 [No Abstract] [Full Text] [Related]
14. First experience with immunomodulation in septic shock. Josten C; Muhr G; Sistermann R Prog Clin Biol Res; 1989; 308():989-94. PubMed ID: 2528747 [No Abstract] [Full Text] [Related]
15. [Various functions of a dual immunity system]. Göing H Arzneimittelforschung; 1974 May; 24(5):819-29. PubMed ID: 4211741 [No Abstract] [Full Text] [Related]